Alliance Pharma plc (APH) — Cash Flow-to-Debt Ratio
Alliance Pharma plc (APH) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2024, meaning its operating cash flow of GBX20.47 Million could theoretically repay 0% of its total liabilities (GBX161.50 Million) in one year. See Alliance Pharma plc (APH) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alliance Pharma plc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Alliance Pharma plc across 28 annual periods. Also explore net asset growth rate of Alliance Pharma plc to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Alliance Pharma plc (1999–2024)
Year-by-year debt coverage analysis for Alliance Pharma plc. For market capitalisation and broader financial context, see APH market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.24x | GBX38.72 Million | GBX161.50 Million | ▲ +50.4% |
| 2023 | 0.16x | GBX31.41 Million | GBX197.05 Million | ▲ +89.8% |
| 2022 | 0.08x | GBX20.97 Million | GBX249.75 Million | ▼ -52.0% |
| 2021 | 0.17x | GBX38.66 Million | GBX221.00 Million | ▼ -4.1% |
| 2020 | 0.18x | GBX41.57 Million | GBX227.90 Million | ▼ -31.9% |
| 2019 | 0.27x | GBX35.76 Million | GBX133.46 Million | ▲ +83.0% |
| 2018 | 0.15x | GBX22.17 Million | GBX151.41 Million | ▼ -26.7% |
| 2017 | 0.20x | GBX26.58 Million | GBX133.10 Million | ▲ +66.9% |
| 2016 | 0.12x | GBX16.93 Million | GBX141.47 Million | ▲ +94.6% |
| 2015 | 0.06x | GBX7.98 Million | GBX129.75 Million | ▼ -80.0% |
| 2014 | 0.31x | GBX11.42 Million | GBX37.09 Million | ▲ +30.0% |
| 2013 | 0.24x | GBX10.03 Million | GBX42.32 Million | ▼ -7.0% |
| 2012 | 0.25x | GBX12.44 Million | GBX48.78 Million | ▲ +11.6% |
| 2011 | 0.23x | GBX8.72 Million | GBX38.16 Million | ▼ -36.6% |
| 2010 | 0.36x | GBX14.89 Million | GBX41.32 Million | ▲ +88.2% |
| 2009 | 0.19x | GBX7.69 Million | GBX40.17 Million | ▲ +193.4% |
| 2008 | 0.07x | GBX2.62 Million | GBX40.07 Million | ▲ +52.4% |
| 2007 | 0.04x | GBX1.70 Million | GBX39.74 Million | ▲ +277.2% |
| 2006 | -0.02x | GBX-910.00K | GBX37.63 Million | ▼ -289.8% |
| 2005 | 0.01x | GBX360.00K | GBX28.26 Million | ▲ +238.3% |
| 2005 | -0.01x | GBX-253.00K | GBX27.47 Million | ▲ +81.1% |
| 2004 | -0.05x | GBX-1.18 Million | GBX24.21 Million | ▼ -204.9% |
| 2003 | 0.05x | GBX976.00K | GBX21.01 Million | ▲ +101.4% |
| 2002 | -3.33x | GBX-80.26K | GBX24.11K | ▼ -3886.0% |
| 2002 | -0.08x | GBX-692.00K | GBX8.29 Million | ▼ -1516.4% |
| 2001 | 0.01x | GBX20.00K | GBX3.39 Million | ▼ -93.2% |
| 2000 | 0.09x | GBX336.00K | GBX3.90 Million | ▼ -59.8% |
| 1999 | 0.21x | GBX1.38 Million | GBX6.45 Million | — |